Biblio Discovery — Demo Discovery Service

9 hasil untuk "Kenneth Atz"

Menampilkan 1–9 · 1,11 detik · RSS

  1. Artikel Jurnal

    QMugs, quantum mechanical properties of drug-like molecules

    Clemens Isert; Kenneth Atz; José Jiménez-Luna dkk.

    Scientific Data, Vol. 9 No. 1 · 2022 · Inggris · DOAJ Scopus

    Measurement(s) Quantum Mechanics Technology Type(s) density functional theory

  2. Artikel Jurnal

    Leveraging molecular structure and bioactivity with chemical language models for de novo drug design

    Michael Moret; Irene Pachon Angona; Leandro Cotos dkk.

    Nature Communications, Vol. 14 No. 1 · 2023 · Inggris · DOAJ Scopus

    Generative Deep Learning holds promise for mining the unexplored “chemical universe” for new drugs. Here, the authors demonstrate the de novo design of phosphoinositide 3-kinase gamma (PI3Kγ) inhibitors for the PI3K/Akt pathway in human tumor cells.

  3. Artikel Jurnal

    G–PLIP: Knowledge graph neural network for structure-free protein–ligand bioactivity prediction

    Simon J. Crouzet; Anja Maria Lieberherr; Kenneth Atz dkk.

    Computational and Structural Biotechnology Journal, Vol. 23 · 2024 · Inggris · DOAJ Scopus

    Protein–ligand interactions (PLIs) determine the efficacy and safety profiles of small molecule drugs. Existing methods rely on either structural information or resource-intensive computations to predict PLI, casting doubt on whether it is possible to perform structure-free PLI predictions at low…

  4. Artikel Jurnal

    Identifying opportunities for late-stage C-H alkylation with high-throughput experimentation and in silico reaction screening

    David F. Nippa; Kenneth Atz; Alex T. Müller dkk.

    Communications Chemistry, Vol. 6 No. 1 · 2023 · Inggris · DOAJ Scopus

    Abstract Enhancing the properties of advanced drug candidates is aided by the direct incorporation of specific chemical groups, avoiding the need to construct the entire compound from the ground up. Nevertheless, their chemical intricacy often poses challenges in predicting reactivity for C-H…

  5. Artikel Jurnal

    Prospective de novo drug design with deep interactome learning

    Kenneth Atz; Leandro Cotos; Clemens Isert dkk.

    Nature Communications, Vol. 15 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract De novo drug design aims to generate molecules from scratch that possess specific chemical and pharmacological properties. We present a computational approach utilizing interactome-based deep learning for ligand- and structure-based generation of drug-like molecules. This method…

  6. Artikel Jurnal

    Expediting hit-to-lead progression in drug discovery through reaction prediction and multi-dimensional optimization

    David F. Nippa; Kenneth Atz; Yannick Stenzhorn dkk.

    Nature Communications, Vol. 16 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract The rapid and economical synthesis of novel bioactive compounds remains a hurdle in drug discovery efforts. This study demonstrates an integrated medicinal chemistry workflow that effectively diversifies hit and lead structures, enabling an acceleration of the critical hit-to-lead…

  7. Artikel Jurnal

    Enhancing Drug Discovery and Development through the Integration of Medicinal Chemistry, Chemical Biology, and Academia-Industry Partnerships: Insights from Roche’s Endocannabinoid System Projects

    Johannes Aebi; Kenneth Atz; Simon M. Ametamey dkk.

    CHIMIA, Vol. 78 No. 7-8 · 2024 · Prancis · DOAJ Scopus

    The endocannabinoid system (ECS) is a critical regulatory network composed of endogenous cannabinoids (eCBs), their synthesizing and degrading enzymes, and associated receptors. It is integral to maintaining homeostasis and orchestrating key functions within the central nervous and immune systems…